ClearPoint Neuro, Inc.
CLPT
$14.70
$0.412.87%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.28% | -12.84% | -6.32% | 10.24% | 3.95% |
| Total Depreciation and Amortization | -4.85% | 6.91% | -2.32% | 11.79% | 0.24% |
| Total Amortization of Deferred Charges | -100.00% | 57.14% | -6.67% | 0.00% | 7.14% |
| Total Other Non-Cash Items | 0.53% | 32.68% | 5.67% | -28.45% | -6.64% |
| Change in Net Operating Assets | 29.84% | 887.21% | 88.84% | -238.45% | 104.97% |
| Cash from Operations | -3.67% | 55.06% | 30.52% | -228.49% | 34.91% |
| Capital Expenditure | -2,091.67% | -- | -- | -- | 91.06% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2,091.67% | -- | -- | -- | 20.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -98.22% | 8,339.58% | -- |
| Repurchase of Common Stock | -37.70% | 52.34% | 15.23% | -308.11% | 59.34% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 100.37% | -6,388.13% | -99.00% | 10,256.77% | 270.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 86.97% | -349.44% | -120.54% | 1,116.06% | 43.36% |